The Health Behavior Research Clinic

HBRC Smoking Clinic

HBRC Smoking Clinic (215-204-6598)

The Smoking Clinic in the HBRC is dedicated to offering state-of-the-art quit smoking and relapse prevention treatments. We are especially interested in providing access to underserved individuals and people who have high risk for smoking-related illnesses, such as asthma and cancer.  Go to this link for directions.

Currently, our smoking treatments are offered at no charge as part of funded treatment research programs, and participants have the opportunity to earn compensation for our evaluation interview assessments.  The HBRC Smoking Clinic is exploring the potential for a more permanent clinic financed by sliding scale, fee-for-service and public health insurance reimbursement. 

OUR CURRENT SMOKING TREATMENTS: 

Philadelphia FRESH:  (215) 204-6598

This treatment study is for maternal (female) smokers with young children.  The main goal of treatment is to protect children from exposure to second-hand smoke.  However, we help any mother who is interested in quitting smoking.  Before you call (215) 204-6598, follow this link to learn more about this treatment, or to complete a screening form online.

Quit 4 Good:  (215) 204-6251

Men and women who are ready to quit smoking and who want to stay quit for good – this treatment is for you!  Participants receive study medication and nicotine gum to help them become ex-smokers.  Before you call (215) 204-6251, follow this link to learn more about this treatment, or to complete a screening form online.

Prenatal and Postpartum Smoking Relapse:  (215) 204-5629

This is a brief health education treatment study for pregnant smokers and recent quitters.  Currently, participation is limited to mothers who plan to have their babies delivered at Temple Children’s Hospital.

OTHER HBRC TREATMENTS:

Skin Savvy Study:  A Skin Cancer Prevention Intervention:

This intervention study targets teens and young adults and is testing different strategies for promoting skin protection to prevent skin cancer in high risk groups.  Participants are compensated for their time in completing surveys to assess treatment effectiveness.